切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2014, Vol. 03 ›› Issue (03) : 193 -195. doi: 10.3877/cma.j.issn.2095-3259.2014.03.011

所属专题: 文献

专家论坛

易栓症与不良妊娠结局的病理改变
贺芳1, 陈敦金1,()   
  1. 1. 510150 广州医科大学附属第三医院妇产科 广州重症孕产妇救治中心
  • 收稿日期:2014-06-10 出版日期:2014-08-18
  • 通信作者: 陈敦金

Pathological changes in thrombophilia with poor pregnancy outcomes

Fang He1, Dunjin Chen1()   

  • Received:2014-06-10 Published:2014-08-18
  • Corresponding author: Dunjin Chen
引用本文:

贺芳, 陈敦金. 易栓症与不良妊娠结局的病理改变[J]. 中华产科急救电子杂志, 2014, 03(03): 193-195.

Fang He, Dunjin Chen. Pathological changes in thrombophilia with poor pregnancy outcomes[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2014, 03(03): 193-195.

妊娠期血液处于高凝状态是生理性的血栓前状态,遗传性和获得性易栓症增加了孕妇血栓形成的几率。虽然易栓症与胎盘介导的妊娠期并发症相关,但是否为直接原因仍未证实。妊娠期易栓症不具备特征性的胎盘病变,故易栓症及妊娠不良结局与胎盘异常病理之间的关系值得进一步研究。

Pregnancy is a physiological prothrombotic state. Genetic and acquired thrombophilia increases the risk of maternal thrombophilia. Thrombophilia is not yet established as a cause of the placenta-mediated pregnancy complications, although the association between thrombophilia and placenta-mediated pregnancy complications is demonstrated. Maternal thrombophilia do not have a characteristic placental lesions. Future study on the relationship of abnormal placental pathology of poor pregnancy outcomes and thrombophilia should be considered.

表1 遗传性易栓症和复发性流产的风险评估[11]
[1]
Kujovich JL. Thrombophilia and pregnancy complications[J]. Am J Obstet Gynecol, 2004, 191(2): 412-424.
[2]
Rodger MA, Paidas M, McLintock C, et al. Inherited thrombophilia and pregnancy complications revisited[J]. Obstet Gynecol, 2008, 112(2 Pt 1): 320-324.
[3]
Rodger MA. An update on thrombophilia and placenta mediated pregnancy complications: what should we tell our patients?[J]. Thromb Res, 2013, 131 (Suppl 1): S25-S27.
[4]
Pierangeli SS, Leader B, Barilaro G, et al. Acquired and inherited thrombophilia disorders in pregnancy[J]. Obstet Gynecol Clin North Am, 2011, 38(2):271-295.
[5]
Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study [J]. Ann Intern Med, 2005, 143(10): 697-706.
[6]
Brill-Edwards P, Ginsberg JS, Gent M, et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of clot in this pregnancy study group[J]. N Engl J Med, 2000, 343(20): 1439-1444.
[7]
Gerhardt A, Scharf RE, Beckmann MW, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium [J]. N Engl J Med, 2000, 342(6):374-380.
[8]
Tam WH, Ng MH, Yiu AK, et al. Thrombophilia among Chinese women with venous thromboembolism during pregnancy[J]. Gynecol Obstet Invest, 2012, 73(3):183-188.
[9]
Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy[J]. N Engl J Med, 1999, 340(5):9-13.
[10]
Arias F, Romero R, Joist H, et al. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta [J]. J Matern Fetal Med, 1998, 7(6):277-286.
[11]
Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review [J]. Br J Haematol, 2006, 132(2):171-196.
[12]
Moldenhauer JS, Stanek J, Warshak C, et al. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent [J]. Am J Obstet Gynecol, 2003, 189(4):1173-1177.
[13]
Toal M, Keating S, Machin G, et al. Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler images[J]. Am J Obstet Gynecol, 2008, 198(3):330.e1-e7.
[14]
Giannakopoulos B, Krilis SA. The pathogenesis of the antiphospholipid syndrome[J]. N Engl J Med, 2013, 368(11):1033-1044.
[15]
Evain-Brion D, Guibourdenche J, Tsatsaris V, et al. Human trophoblast differentiation[J]. Bull Acad Natl Med, 2009, 193(5):1017-1025.
[16]
Franco C, Walker M, Robertson J, et al. Placental infarction and thrombophilia [J]. Obstet Gynecol, 2011, 117(4): 929-934.
[17]
Isermann B, Sood R, Pawlinski R, et al. The thrombomodulin-protein C system is essential for the maintenance of pregnancy [J]. Nat Med, 2003, 9(3): 331-337.
[18]
Battinelli EM, Marshall A, Connors JM. The role of thrombophilia in pregnancy[J]. Thrombosis, 2013, 2013: 516420.
[1] 魏宇婷, 罗红. 超声弹性成像评价胎儿生长受限的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 256-260.
[2] 冯丹艳, 曹晓辉, 史玉霞. 血清脂联素与胎盘亮氨酸氨肽酶对妊娠期糖尿病患者妊娠结局的影响[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 302-308.
[3] 匡德凤, 李志国, 华绍芳, 薛凤霞. 高脂诱导孕鼠血清及胎盘组织脂肪酸结合蛋白-4及相关脂蛋白水平变化及其意义[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 338-344.
[4] 吴晓翔, 杨波, 李景漩, 张凤玲, 郭桂辉, 郑少培. 脐动脉超声检查联合NLR、sFlt-1/PLGF对妊娠高血压综合征患者不良妊娠结局的预测价值[J]. 中华临床医师杂志(电子版), 2023, 17(03): 266-271.
[5] 赵先兰, 周艳. 胎盘植入性疾病出血血管介入治疗策略[J]. 中华产科急救电子杂志, 2023, 12(03): 147-150.
[6] 陈颖, 曾万江. 病理组织学诊断在胎盘植入性疾病中的作用和意义[J]. 中华产科急救电子杂志, 2023, 12(03): 143-146.
[7] 中国医师协会妇产科分会母胎医学专委会, 中华医学会围产医学分会重症学组. 预防性介入治疗在胎盘植入性疾病的应用专家共识(2023)[J]. 中华产科急救电子杂志, 2023, 12(03): 133-140.
[8] 郭志荣, 马京梅. 胎盘植入性疾病的风险评估和治疗策略[J]. 中华产科急救电子杂志, 2023, 12(03): 151-154.
[9] 张丽姿, 陈敦金. 胎盘植入性疾病的不良结局及远期影响[J]. 中华产科急救电子杂志, 2023, 12(03): 155-158.
[10] 古士锋, 张丽姿, 梁景英, 杜丽丽, 孙雯, 陈敦金. 2011-2021年我国胎盘植入性疾病研究热点:基于CiteSpace可视化分析[J]. 中华产科急救电子杂志, 2023, 12(03): 159-166.
[11] 岳永飞, 朱利平, 王晓艳. 磁共振成像技术在预测胎盘植入性疾病患者剖宫产术中出血量的研究[J]. 中华产科急救电子杂志, 2023, 12(03): 167-172.
[12] 王永, 李霞林, 杨蓉, 潘康妮, 余琳, 王伟伟, 孙雯, 陈敦金. 胎盘植入合并严重产后出血输血方案的研究[J]. 中华产科急救电子杂志, 2023, 12(03): 173-179.
[13] 吴文诗, 魏宋荃, 李桂民, 郑晓芳, 孙雯, 陈敦金, 余琳. 胎盘植入性疾病患者行子宫部分切除术后再次妊娠的临床研究[J]. 中华产科急救电子杂志, 2023, 12(03): 180-186.
[14] 陆晓勤, 刘先保, 龙尚乾, 宋可欣, 邓艳红, 张春芳. 不同程度胎盘植入患者剖宫产的麻醉决策及母婴结局[J]. 中华产科急救电子杂志, 2023, 12(03): 187-192.
[15] 向雷, 杨琪, 谢辉, 刘海涛, 夏风, 兰为顺, 杨文忠. 非顺应性腹主动脉球囊阻断术在凶险性前置胎盘伴胎盘植入剖宫产中的应用[J]. 中华介入放射学电子杂志, 2023, 11(02): 106-112.
阅读次数
全文


摘要